Understanding real court cases helps make sense of legal concepts. In this blog, we explain important Indian patent case laws in simple words. If you are preparing for the patent agent exam, especially Paper II or the interview, this blog is a must-read.
Let’s Start with a Simple Thought
When someone says “case law,” most students feel confused.
“Too many long judgments.”
“Too many difficult words.”
“Too much to remember.”
But what if we could explain it all like a story?
That’s what this blog is about — real stories from Indian courts that made big changes in how we understand patent law.
Why You Must Know These Cases
If you are preparing for the Indian Patent Agent Examination, here’s why learning case laws is important:
- Questions from these cases may appear in Paper II.
- Interviewers often ask about famous patent disputes.
- These cases help you understand how laws are applied in real life.
- You will understand what courts expect from a “valid patent”.
In short, these case laws are like real examples of the rules you are studying.
What Will You Learn in This Blog
- A short and simple explanation of landmark patent cases in India
- What happened in each case
- What the court decided
- Why it is important for the patent agent exam
You don’t need to memorise long judgments. Just remember the key ideas from each case.
Tip: Bookmark this page. It may help you just before the exam or interview.
Let’s Dive into the Landmark Indian Patent Cases
1. Novartis AG vs Union of India (2013)
Main Point:
The case was about Section 3(d) of the Indian Patents Act.
What Happened:
Novartis made a cancer drug called Glivec. Later, they made a slightly new form of the same medicine and applied for a new patent in India.
What the Court Said:
The court said the new form was not truly different. It did not show better results. So, no new patent could be given.
Why This Case Matters:
This case explained that small changes to old inventions cannot get new patents. It stopped the practice of “evergreening” — extending patent life with minor changes.
2. Bayer Corporation vs Union of India & Natco Pharma (2014)
Main Point:
This case introduced compulsory licensing in India.
What Happened:
Bayer had a patent for a cancer drug (Nexavar). But the medicine was priced too high — around ₹2.8 lakh per month.
Natco Pharma, an Indian company, wanted to make a cheaper version. They applied for a compulsory licence.
What the Court Said:
The court approved the compulsory licence. Natco was allowed to make and sell the medicine at a lower price.
Why This Case Matters:
It showed that when public health is at risk, patent rights can be limited. This helps make medicines more affordable in India.
3. Biswanath Prasad Radhey Shyam vs Hindustan Metal Industries (1978)
Main Point:
This case focused on the inventive step requirement.
What Happened:
A patent was granted for a machine used in making utensils. But the opposing side argued it was too simple and anyone with basic knowledge could have made it.
What the Court Said:
The court agreed. The invention lacked an inventive step. It was obvious to someone skilled in the field.
Why This Case Matters:
It defined what “inventive step” means. To get a patent, the invention must not be something obvious.
4. F. Hoffmann-La Roche vs Cipla (2008)
Main Point:
This case dealt with patent infringement vs public interest.
What Happened:
Cipla, an Indian company, started selling a generic version of Roche’s patented cancer drug. Roche said Cipla was violating its patent rights.
What the Court Said:
Even though Cipla had used a patented formula, the court focused on public interest. The medicine was life-saving and expensive.
Why This Case Matters:
This case showed that affordable access to medicine can be a key factor in such disputes. Public interest can influence the final judgment.
5. Merck Sharp & Dohme vs Glenmark Pharmaceuticals (2015)
Main Point:
This case explained infringement and validity of a patent.
What Happened:
Merck had a patent on a diabetes drug. Glenmark made a similar medicine without permission.
What the Court Said:
The court said Glenmark had infringed Merck’s patent. Even though they made a small change, the core idea was the same.
Why This Case Matters:
A small tweak is not enough to escape infringement. If the basic invention is copied, it can still be considered a violation.
Quick Summary Table of Key Cases
| Case Name | Main Issue | Key Takeaway |
| Novartis vs Union of India | Section 3(d), Evergreening | Minor improvements don’t get new patents |
| Bayer vs Natco Pharma | Compulsory Licensing | Life-saving drugs must be accessible |
| Biswanath vs Hindustan Metals | Inventive Step | Patents need non-obvious, innovative ideas |
| Roche vs Cipla | Public Interest | Affordable healthcare can influence decisions |
| Merck vs Glenmark | Infringement | Changing small things doesn’t avoid infringement |
Other Cases to Keep in Mind (Not Asked Often, but Good to Know)
- Enercon (India) vs Enercon GmbH – Related to patent rights within business partners
- Ericsson vs Micromax and Intex – Related to FRAND terms and Standard Essential Patents (SEPs)
These may not appear in the exam often, but interviewers may mention them.
How to Remember These Indian Patent Cases Easily
Here’s a simple trick to remember all this without stress:
- Use a one-line story for each case.
- Create flashcards with case name on one side and the issue on the other.
- Revise regularly — once a week is enough before the exam.
Example:
“Novartis changed old drug slightly. Court said: No patent for that.”
Midway Tip
Take a moment to bookmark this blog.
Later, when you revise before the exam or interview, you’ll be happy to find all the cases clearly explained in one place.
Final Thoughts
Laws can be confusing. But real cases help make them simple. These cases show how patent law works in actual situations — not just on paper.
If you want to succeed in the patent agent exam:
- Understand what the court decided
- Learn why those decisions matter
- Practice using these cases in mock answers or viva prep
Remember, you don’t need to be a legal expert to understand case law.
You just need a clear explanation — and now you have it.
Checklist Before You Go
- Learn the top 5 landmark cases
- Know what Section 3(d), inventive step, and compulsory licence mean
- Revise each case using short summaries
- Practice writing answers using these cases
